Skip to main content

Advertisement

SpringerLink
Log in

Association of interleukin (IL)-4 intron-3 and IL-6 −174 G/C gene polymorphism with susceptibility to end-stage renal disease

  • Original Paper
  • Published:
Immunogenetics Aims and scope Submit manuscript

Abstract

Earlier studies suggest that end-stage renal disease (ESRD) is associated with inflammatory state and have become a major cause of morbidity and mortality worldwide. This study speculated the role of interleukins (IL)-2, -4, and -6 cytokines gene polymorphism with risk of susceptibility to ESRD. Polymorphism in IL-2 (−330 T/G, polymerase chain reaction [PCR]-restriction fragment length polymorphism), IL-4 (intron-3, variable number of tandem repeat, variable number tandem repeats analysis), and IL-6 (-174 G/C, amplification refractory mutation system, i.e. ARMS-PCR) were genotyped in 193 ESRD patients and 180 controls. Significant difference was observed in genotype frequencies of IL-4 and IL-6 between ESRD patients and control group (p < 0.001 and p = 0.032, respectively). Patients had higher frequency of homozygous B2B2 genotype (IL-4) than controls (62.7% vs 46.7) and GG genotype of IL-6 (73.1% vs 60.6%). The genotypic frequencies of IL-2 were comparable in patients and controls (p = 0.102). Significant association of IL-4 was also observed in patients with glomerulonephritis (p = 0.001). Combination of low IL-4 and high IL-6 genotypes were significantly associated with ESRD showing the highest risk, i.e. >threefolds risk (odds ratio=3.48, 95%CI=1.88–6.42; p < 0.001) among the four possible combinations taking high IL-4 and low IL-6 as reference. Our study suggests that polymorphism in IL-4 and IL-6 may be associated with susceptibility to ESRD. Further, combined analysis implicated a higher risk in ESRD patients with low IL-4 and high IL-6 producing genotypes. This study provided the basis for defined anti-inflammatory approaches to limit renal disease progression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Akira S, Taga T, Kishimoto T (1993) Interleukin-6 in biology and medicine. Adv Immunol 54:1–78

    PubMed  CAS  Google Scholar 

  • Balakrishnan VS, Guo D, Rao M, Jaber BL, Tighiouart H, Freeman RL, Huang C, King, AJ, Pereira BJ; HEMO Study Group (2004) Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 65:1449–1460

    Article  PubMed  CAS  Google Scholar 

  • Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D, Stenzel KH, Rubin AL (1998) Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107–114

    PubMed  CAS  Google Scholar 

  • Bowcock AM, Kidd JR, Lathrop GM, Daneshvar L, May LT, Ray A, Sehgal PB, Kidd KK, Cavalli-Sforza LL (1988) The human “interferon-beta 2/hepatocyte stimulating factor/interleukin-6” gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 3:8–16

    Article  PubMed  CAS  Google Scholar 

  • Buchs N, Silvestri T, di Giovine FS, Chabaud M, Vannier E, Duff GW, Miossec P (2000) IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction. Rheumatology (Oxford) 39:1126–1131

    Article  CAS  Google Scholar 

  • Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG (2001) Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus host disease in HLA-matched sibling bone marrow transplantation. Blood 98:1594–1600

    Article  PubMed  CAS  Google Scholar 

  • Chomarat P, Vannier E, Dechanet J, Rissoan MC, Banchereau J, Dinarello CA, Miossec P (1995) Balance of IL-1 receptor antagonist/IL-1 beta in rheumatoid synovium and its regulation by IL-4 and IL-10. J Immunol 154:1432–1439

    PubMed  CAS  Google Scholar 

  • Collins AJ, Kasiske B, Herzog C, Chen SC, Everson S, Constantini E, Grimm R, McBean M, Xue J, Chavers B, Matas A, Manning W, Louis T, Pan W, Liu J, Li S, Roberts T, Dalleska F, Snyder J, Ebben J et al (2003) Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 42(6 Suppl 5):A5–A7

    PubMed  Google Scholar 

  • Cox ED, Hoffmann SC, DiMercurio BS, Wesley RA, Harlan DM, Kirk AD, Blair PJ (2001) Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation 72:720–726

    Article  PubMed  CAS  Google Scholar 

  • DeMichele A, Martin AM, Mick R, Gor P, Wray L, Klein-Cabral M, Athanasiadis G, Colligan T, Stadtmauer E, Weber B (2003) Interleukin-6 −174G→C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res 63:8051–8056

    PubMed  CAS  Google Scholar 

  • Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jungers P et al (1995) Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 154:882–892

    PubMed  CAS  Google Scholar 

  • Dong J, Fujii S, Goto D, Furumoto T, Kaneko T, Zaman TA, Nakai Y, Mishima T, Imagawa S, Kitabatake A (2003) Increased expression of plasminogen activator inhibitor-1 by mediators of the acute phase response: a potential progenitor of vasculopathy in hypertensives. Hypertens Res 26:723–729

    Article  PubMed  CAS  Google Scholar 

  • Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376

    Article  PubMed  CAS  Google Scholar 

  • Furusu A, Miyazaki M, Koji T, Abe K, Ozono Y, Harada T, Nakane PK, Hara K, Kohno S (1997) Involvement of IL-4 in human glomerulonephritis: an in situ hybridization study of IL-4 mRNA and IL-4 receptor mRNA. J Am Soc Nephrol 8:730–741

    PubMed  CAS  Google Scholar 

  • Gyan BA, Goka B, Cvetkovic JT, Kurtzhals JL, Adabayeri V, Perlmann H, Lefvert AK, Akanmori BD, Troye-Blomberg M (2004) Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children. Clin Exp Immunol 138:145–150

    Article  PubMed  CAS  Google Scholar 

  • Hiromura K, Kurosawa M, Yano S, Naruse T (1998) Tubulointerstitial mast cell infiltration in glomerulonephritis. Am J Kidney Dis 32:593–599

    PubMed  CAS  Google Scholar 

  • Hoffmann SC, Stanley EM, Darrin Cox E, Craighead N, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ (2001) Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 72:1444–1450

    Article  PubMed  CAS  Google Scholar 

  • Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M (2001) Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren’s syndrome and correlate with the clinical manifestations of the disease. Rheumatology 40:656–661

    Article  PubMed  CAS  Google Scholar 

  • Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ (2001) The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22:2243–2252

    Article  PubMed  CAS  Google Scholar 

  • John S, Turner D, Donn R, Sinnott P, Worthington J, Ollier WE, Hutchinson IV, Hajeer AH (1998) Two novel biallelic polymorphisms in the IL-2 gene. Eur J Immunogenet 25:419–420

    Article  PubMed  CAS  Google Scholar 

  • Kanda T, Takahashi T (2004) Interleukin-6 and cardiovascular diseases. Jpn Heart J 45:183–193

    Article  PubMed  CAS  Google Scholar 

  • Kelley VR, Wuthrich RP (1999) Cytokines in the pathogenesis of systemic lupus erythematosus. Semin Nephrol 19:57–66

    PubMed  CAS  Google Scholar 

  • Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, Chen L, Jeyarajah DR, Zhou XJ, Zhou H, Chiquett B, Nagami GT, Lu CY (2005) Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 16:3315–3325

    Article  PubMed  CAS  Google Scholar 

  • Le Beau MM, Lemons RS, Espinosa R, Larson RA, Arai N, Rowley JD (1989) Interleukin-4 and interleukin-5 map to human chromosome 5 in a region encoding growth factors and receptors and are deleted in myeloid leukemias with a del (5q). Blood 73:647–650

    PubMed  Google Scholar 

  • Masutani K, Miyake K, Nakashima H, Hirano T, Kubo M, Hirakawa M, Tsuruya K, Fukuda K, Kanai H, Otsuka T, Hirakata H, Iida M (2003) Impact of interferon-gamma and interleukin-4 gene polymorphisms on development and progression of IgA nephropathy in Japanese patients. Am J Kidney Dis 41:371–379

    Article  PubMed  CAS  Google Scholar 

  • Mier JW, Vachino G, van der Meer JW, Numerhof RP, Adams S, Cannon JG (1988) Induction of circulating tumor necrosis factor as the mechanism for the febrile response to IL-2 in cancer patients. J Clin Immunol 8:426–436

    Article  PubMed  CAS  Google Scholar 

  • Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215

    Article  PubMed  CAS  Google Scholar 

  • Mout R, Willemze R, Landegent JE (1991) Repeat polymorphisms in the interleukin-4 gene (IL4). Nucleic Acids Res 19:3763

    Article  PubMed  CAS  Google Scholar 

  • Nakajima A, Hirose S, Yagita H, Okumura K (1997) Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J Immunol 158:1466–1472

    PubMed  CAS  Google Scholar 

  • Paul WE, Seder RA (1994) Lymphocyte responses and cytokines. Cell 76:241–251

    Article  PubMed  CAS  Google Scholar 

  • Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P (2002) Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684–1688

    Article  PubMed  CAS  Google Scholar 

  • Pecoits-Filho R, Lindholm B, Axelsson J, Stenvinkel P (2003) Update on interleukin-6 and its role in chronic renal failure. Nephrol Dial Transplant 18:1042–1045

    Article  PubMed  CAS  Google Scholar 

  • Singh RR, Saxena V, Zang S, Li L, Finkelman FD, Witte DP, Jacob CO (2003) Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J Immunol 170:4818–4825

    PubMed  CAS  Google Scholar 

  • Stenvinkel P, Alvestrand A (2002) Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 15:329–337

    Article  PubMed  Google Scholar 

  • Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M, Heimburger O, Cederholm T, Girndt M (2005) IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia—the good, the bad, and the ugly. Kidney Int 67:1216–1233

    Article  PubMed  CAS  Google Scholar 

  • Strutz F, Neilson EG (1994) The role of lymphocytes in the progression of interstitial disease. Kidney Int Suppl 45:S106–S110

    PubMed  CAS  Google Scholar 

  • Tan D, Wu X, Hou M, Lee SO, Lou W, Wang J, Janarthan B, Nallapareddy S, Trump DL, Gao AC (2005) Interleukin-6 polymorphism is associated with more aggressive prostate cancer. J Urol 174:753–756

    Article  PubMed  CAS  Google Scholar 

  • Walley AJ, Cookson WO (1996) Investigation of an interleukin-4 promoter polymorphism for associations with asthma and atopy. J Med Genet 33:689–692

    Article  PubMed  CAS  Google Scholar 

  • Yao Q, Lindholm B, Stenvinkel P (2004) Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients. Hemodial Int 8:118–129

    Article  Google Scholar 

  • Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209–214

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The authors are grateful to the Director, Sanjay Gandhi Institute of Medical Sciences for providing the necessary facilities. Ms. P. K. Manchanda is thankful to the Council of Scientific and Industrial Research New Delhi for awarding junior research fellowship (JRF).

Author information

Authors and Affiliations

  1. Department of Urology and Renal Transplantation, Sanjay Gandhi post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow, 226014, India

    Rama Devi Mittal & Parmeet Kaur Manchanda

Authors
  1. Rama Devi Mittal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Parmeet Kaur Manchanda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rama Devi Mittal.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mittal, R.D., Manchanda, P.K. Association of interleukin (IL)-4 intron-3 and IL-6 −174 G/C gene polymorphism with susceptibility to end-stage renal disease. Immunogenetics 59, 159–165 (2007). https://doi.org/10.1007/s00251-006-0182-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00251-006-0182-6

Keywords

Search

Navigation